The Trust acknowledged a paramedic's lack of awareness regarding Rivaroxaban and is implementing an action plan for individual learning and organizational changes. They will ensure all clinical staff are aware of the effects of Novel Oral Anti-coagulant drugs. (AI summary)
View full response
Whilst the Trust acknowledges that during the Inquest you heard verbal evidence from the paramedic who attended Prance, would Ilke to take the opportunlty t0 confirm with you that during 2014 a Clinical Notice number 18 entitled, Novel Oral Anti- coagulant; was published to all clinicians. In that document anti-coagulant therapies including Rivaroxaban were referred to and advice was supplied to staff regarding their use. attach for your reference a copy of that Clinical Notice attach for your reference an action plan that illustrates the actions the Trust will be taking as a direct result of the Regulation 28 Report received from you, this covers both individual learning for Ihe paramedic who provided evidence at the Inquest; as well as arganisational actions t0 ensure that all of our clinical staff are aware of the effects of these Novel Oral Anti-coagulant drugs. would like t0 extend the offer t0 meet with you t0 discuss our response in more detail and to provide you with any further assurances you make require regarding our commitment to continuous improvement: